← All organizations

Tris Pharma, Inc.

For profitWebsite ↗

Also known as: Tris Pharma, Inc. | TRIS PHARMA INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Jul 31, 2025

Timeline

2000s

Jun 1, 2000
Tris Pharma, Inc.— Founded

2010s

Oct 19, 2015
amphetamine— NDA Secondary Org
Aug 26, 2016
dexmethylphenidate— Marketing Organization

Drugs by trial phase (5 distinct, 7 trials)

Phase 4 (1 own, 0 via acquisition)

clonidine

Phase 3 (1 own, 0 via acquisition)

amphetamine

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT07044609CollaboratorPhase 4Jul 31, 2025
NCT05491785Lead sponsorPhase 1Jul 29, 2022
NCT05256108Lead sponsorPhase 1Mar 28, 2022
NCT04027361Lead sponsorPhase 2Dec 31, 2019
NCT03834766Lead sponsorPhase 3Feb 6, 2019
NCT03088267Lead sponsorPhase 3Feb 11, 2017
NCT02083783Lead sponsorPhase 3Mar 1, 2014

Details

Founded: Monmouth Junction, NJ, US Jun 1, 2000
Last known activity: Jul 31, 2025